Kite Pharma Inc. (NASDAQ:KITE)
Old Forum Content for KITEMake a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- tennessee9: $kite - should we let this "fly" or.....! novice/tennessee
- Gmoore: @DAN $JUNO $KITE $BLUE $CELG Still holding these?
- DAN: $JUNO $KITE $BLUE $CELG These biotech stocks look good today. I covered them in our last strategy session. Bought some KITE and JUNO today. Will also be buying some BLUE and CELG. KITE and JUNO are big competitors of CELG/BLUE. Bluebird seems to have a head start...but I like the underdogs.
- ROSEY: @DAN $JUNO $KITE $BLUE $CELG If possible, pls tell if U like these individuals better than etf IBB and IBB currently more than XBI? Why the underdogs?
- DAN: @tejas7 $BLUE I don't know of any catalyst specifically for Bluebird. Novartis ($NVS) has a drug that goes before the FDA later this month. IF they get approval, that'll set the stag for KITE's ($KITE) drug later this year. $BLUE and $JUNO have their own things going...but those are 2018 projects. So the real "catalyst" for BLUE would be good news for NVS/KITE
- DAN: @ROSEY $JUNO $KITE $BLUE $CELG What are you calling "underdogs"? Not understanding your question (re/ IBB/XBI -- they're moving just about the same).
- ROSEY: @DAN $JUNO $KITE $BLUE $CELG Thanks for reply on IBB and XBI. My question re underdogs relates to your post this A.M. "Bluebird seems to have a head start...but I like the underdogs". I was just seeking names of the ones you considered the underdogs.
- audrina0904: @ROSEY $JUNO $KITE $BLUE $CELG Rosey - he is referencing the analysis in a report at IBD that states that $BLUE has a pretty good lead in their field over $JUNO and $KITE... This was corroborated today by another analyst.
- ROSEY: @audrina0904 $JUNO $KITE $BLUE $CELG Thank you for this info.
- DAN: @ROSEY $JUNO $KITE $BLUE $CELG Underdogs are just KITE/JUNO b/c their drugs are coming out later. But the charts are what matter.
- DAN: Good morning! Hope you had a relaxing weekend and were able to spend some time with your family and friends, doing things other than persevering about trading. If not, you'll get another chance this afternoon and tomorrow. The exchanges close earl ...
- gwenzee: @woodman #Medical Currently holding $ABMD (Med. Device) and Biotechs $INCY $KITE $PBYI $BLUE. All positive with exception of BLUE. May I ask what you are holding?
- michaelH: @woodman $CARA #Biotechs #Biotech So true. Look at $Omer, glad I sold mine in stages on the way up. Sold my $kite 2 days ago, and not looking back, even though it hasn't cratered yet. Buy small and sell the pops in stages is the only way!!!!
- woodman: @gwenzee $ABMD $INCY $KITE $PBYI $BLUE #Medical - My current #biotechs are $CEMP and $CALA . The third one I mentioned is $ATRS, but that's the one I said isn't a biotech (it's med instrument-supply). I've traded $ATRS many times over the years. My last buy back was at $2.60 and I sold most of it recently at $3.17. I still have a little of it. Another I recently had but no longer is $DVAX. I bought $DVAX in the $7.80s and a little more at $8.85, and sold it all at $9.95. I will look to buy DVAX back after this pullback. (Note that DVAX has it's FDA Advisory panel coming July 28.) I have a number of medical instrument-supply/diagnostic-research/medical device stocks as well. I do not have $ABMD, but it is on my watch list and I like it around here as it moves sideways into the rising 50 day.
- gwenzee: @michaelH $CARA $Omer $kite #Biotechs #Biotech Was kicking myself for not buying OMER. In retrospect glad I didn't try to chase.
- shoredriver: $BLUE...Anybody follow closely?... Was in got out and sort of forgot about it...$JUNO $KITE too.....
- CHOFF: @shoredriver $BLUE $JUNO $KITE Got back in at 111.70. Price target is 125 by some prognosticators. Search the forum for latest updates on their positive news on cancer drug trial tests. This one is volatile and could spike or bottom out at any time. Since the trial results are so positive I'm comfortable holding for now.
- Bridget: $XBI at a new 52 week high. We haven't been talking about biotechs too much. Looks about ready to break out of this triangle. $KITE also hitting a new 52 week high.
- shoredriver: $KITE bigger loss and patient death....thought it would be down more...
- gwenzee: @bigbartabs $LABD $EXAS $KITE reported lower earnings and also a patient death in Car-T trial. Pulling all down with it. Hoping Tues. sees a snapback bounce. Or... is that too much to hope for?
- debeers: $EXAS- No patient deaths in Exact Sciences Miss Gwen. You send your poop away to be tested. I am sure that those reading about$ KITE may have been confused.NP $KITE.
- bigbartabs: @gwenzee $LABD $EXAS $KITE ... well, its always to much to hope for. But let's do it anyway... wada ya say??
- Bridget: Notes: Quite a few good performing stocks pulling back today. Taking a breather. Closed a lot more positions today than I opened. $BA - cup and handle pattern $XLNX - nice cup patterm $MRCY - new 52 week high $SODA - working $KTOS - new all time high $TSEM - new all time high $AAOI - resistance still at $60 $NWL - good ER, breakout from consolidation $WYNN $MLCO - profit taking looks done. Can look at possible entry. $KITE - breakout and down, $JUNO followed $CELG - breakout and down, looking at $115-116 for support $AMC - ER this afternoon, Weekly chart looks like a short set-up $COMM - still holding at 200ma $RL - another try to breakout but pulled back $DDD - 3D printing stocks up big today
- shoredriver: $KITE continues...
- cmaxwel1: @Bridget $GDX $UUP $ULTA $MTN $FIZZ $SHLD $WLDN $FNSR $ACIA $OCLR $PAY $ZUMZ $IBB $ABBV $VRTX $AMGN $MDT $KITE $TTPH $AUPH $XLK $SMH $AMD $AVGO $ATHM $AEIS $LRCX $SWKS $VEEV $MRVL $RMP $ZIOP $HOG $PII $T $AON $HTZ $RH $PANW (big volume on $PANW). Adding on monday
$IBB - biotech uptoday. Here are some stocks that are working. $ABBV $VRTX $AMGN $MDT $KITE $TTPH $AUPH
$XLK - tech and semis still doing well $SMH $AMD $AVGO
Working: $ATHM $AEIS $LRCX $SWKS $VEEV
$MRVL - breaking out on volume about Investor' ...
- 1993dean: DAN how would you play $kite
- TunaHelper: In addition to reporting earnings pre-market, $KITE reported positive results from it non-Hodgkins lymphoma drug study. Shares halted.
- TunaHelper: $KITE resumed (obv. trading higher).
- TunaHelper: $KITE Per AM note, this was halted PM and it (the stock $KITE) had a significant short position. It's starting to fade. Out.
9) KTE-C19 (axicabtagene ciloleucel) Non-Hodgkins Lymphoma - $KITE - First CAR-T drug approval.
10) INGREZZA - (Valbinazine) $NBIX First FDA approved for Tardive Dyskinesia which causes lip-smacking, grimacing and blinking. PDUFA April 11
- Bridget: $KITE and $BLUE are both making a move higher, while $JUNO is making new lower lows.
- issues: @Bridget $KITE $BLUE $JUNO IBD ratings for $KITE = composite 25, accumulation A+ (best). $BLUE 47 B. $JUNO 10 D . We hold $ILMN for a bounce.$ ILMN is in group 151 Med Research.$ BLUE $KITE and $JUNO are in group 44 with $CELG $CBPO (own) $REGN $INCY. Thank you!
- traderbren: $BLUE and $KITE - nice bounce trades on $JUNO dump.
- gwenzee: $JUNO $KITE This is why Bios are so dangerous.
- DAN: @gwenzee $JUNO $KITE Totally agree. Zippity zip one way...then zippity zip the other way. (I don't know why I wrote zippity zip. It just seemed appropriate).
- Lou: @DAN $JUNO $KITE - and $CEMP is also yoyo-ing.
- gwenzee: @DAN $JUNO $KITE You were probably thinking of zippity doo dah and got lost along the way.
- bigbartabs: @DAN @gwenzee $JUNO $KITE ... zippity zip... I think these two tickers are the market equivalent of that "REROUTING" voice on my GPS.
- woodman: $JUNO proving to be the better play than $KITE off of KITE's news.
- kshaggy456: @woodman $JUNO $KITE do you think gild might buy one of these companies?
- Christopher: $KITE halted AH
- traderbren: @Christopher $KITE - also keep an eye on $JUNO
- orpheusredux: @Christopher $KITE I've been in and out of this name the last few weeks. Was out when it popped but jumped in AH at 59.43 after it drifted down from the initial euphoria high. Good thus far. Company is a potential b/o target anyway so I'm happy to own it.
- Christopher: @orpheusredux $KITE Nice trade. Good luck!
- orpheusredux: @woodman $OPHT Me too. Dipped a toe in. Like it better than $KITE right now but basically like prospects of both.
- orpheusredux: I think it's safe to buy $OPHT here. $KITE, not sure. Staying away. As for $OPHT, I'm not buying just yet but watching closely. If it ticks up a bit, then I'll dip a toe in.
- orpheusredux: $KITE bounced right off that 200 day. I'm still unwilling to pay up for it here, but would like to get back in eventually. Will wait till the 5 DMA turns up first.
- orpheusredux: I won't believe the mini-rally in $KITE until the 5 DMA starts rising again. Meanwhile, $OPHT is starting to look interesting again. Approaching the 200 day.
- orpheusredux: @steve71 $OPHT Agree. Love the story and it looks as if it could find support here. I'm watching for a decisive upturn and then will jump back in. Likewise with $KITE. Both possible b/o targets/
- orpheusredux: As I suspected, $KITE not ready to fly higher just yet. Watching...waiting...
- orpheusredux: @Aragorn $KITE Thank you, Aragorn. I will research it. Never heard of this one.
- orpheusredux: While I don't think $KITE will suffer the same fate as $OPHT, I'm staying away from it for the time being. Made a nice gain in it last week, got stopped out and now just watching.
- orpheusredux: Big buying in $KITE pushed it into the green at the end of the session but I'm still guarded on this name. Would love to see it pull back to 58.6 or the 20 EMA and hold. Looks a little tired here.
- orpheusredux: $KITE has now pulled back 3 days in a row. I like this name a lot but am suspicious of it here. If it holds and turns north, I'll jump back in. But will wait for it to declare its true intentions. If it heads south, next support is at 58.60-ish.
- Aragorn: @orpheusredux $KITE That is one of my favorite setups a 3 day pullback to a rising 8ema held there and you have a hammer so if you want do nothing today and take a position above the hammer tomorrow or go in today stop below todays LOD. Par Sar shifted to a short today but do not let that be a major concern just note it if it does not bounce tomorrow the 21ema is the next stop
- orpheusredux: @Aragorn $KITE I agree. And it did make a little hammer today. Encouraging. The only thing I don't understand is Par Sar. What's that short for?
- Aragorn: @orpheusredux $KITE Paraboli Stop And Reverse. An Indicator, do a search on it I have been talking about it for a couple of years or more. Search here or investopedia. Dan has mentioned it as well
- orpheusredux: $KITE has pulled back to the 5 day. I was stopped out yesterday with a smallish gain and am looking to re-enter, but not before Fed speaks. Potential buying opp here if you missed it. If it pulls back to 58.6, it's found support there recently and right now the breakout looks intact.
- orpheusredux: $KITE remains strong. But is it pausing here to catch its breath or about to pull back? I'm betting on the former but have stop in place.
- orpheusredux: $KITE continues its impressive breakout. Up nearly 3%.
- Bridget: Notes: $LN - working $X - getting a bounce $HIMX - day 3, wait for pullback but then enter $EBIO / $SGYP / $TWLO - inverted hammer, this rally just might be an exhaustion $KITE - working $V - breaking out, look at weekly. I like the Oct $80 calls $AAPL - working $FIT / $CNX - like the stocks that are moving higher out of flag patterns right now $ALL / $MCK - in a squeeze $MPEL - breaking the downward trend $TPB - another IPO working $FDX - making a move $GS - moving higher now
- orpheusredux: $KITE had a nice day today and I got back in after it seemed to declare itself. The chart looks very cup-with-handle-y and the way this runs, I could see a quick sprint to 65 in the near term.
- orpheusredux: I really like $KITE's prospects but it looks like it may roll back to the 200 DMA. It can't hold 59 and the 5 DMA looks like it's turning down. Will watch for a good entry around 56.
- orpheusredux: $KITE may be giving you an opportunity to get in below $60. Stock recovered nicely all day yesterday after initial 5% drop on ER. Looks like it's consolidating recent gains but sitting at YTD high
- orpheusredux: $KITE coming back to earth after ER today. Looking for re-entry (sold a few days before earnings). Sitting right on 200 DMA but wouldn't be surprised to see it drop to the 20, in which case, I'll be pulling its string.
- orpheusredux: After its strong comeback from morning lows, I threw caution and $KITE to the wind and got back in at $58.30. Looks like this morning WAS the pullback. Stop a little below today's low.
- orpheusredux: $KITE reports after hours today. I took my profits last week (sadly, a day or two early--missed the big up day). If it pulls back after ER, will look to re-enter. Great story and lately, great stock. Could head back to resistance at 66 level.
- orpheusredux: $KITE I stupidly took profits way too early a few sessions ago. (Why didn't I just sell half?) The chart looks great, but they report Monday AH so prudence suggests waiting and hoping for a drop a la $ACAD, which gave a nice re-entry to those who sold yesterday prior to earnings. I actually did sell about 40% of my $ACAD but may not jump back in just yet. If it starts running above $38, I'll definitely buy.
- orpheusredux: I wonder how others feel...for me one of the very hardest parts of trading is resisting the overwhelming urge to buy. Resisting the Fear Of Missing Out emotion. But I'm getting better at conquering it. I've learned to tell myself that you can never really miss out because there's always something running. There's more than one train in the depot. In fact, it's frickin' Grand Central Station. So instead of FOMO, I prefer JONGITE (Joy of Not Getting In Too Early). There's a satisfaction in having cash at the ready for when that deluxe Bullet Train comes along. Anyway, this is what keeps me from jumping back into $ACAD and $KITE on a day like today. All aboard? No, thank you, Mr. Conductor. I'll wait.
- valerie: @orpheusredux $ACAD $KITE thanks for sharing, I suffer from FOMO too, it's a battle :-)
- orpheusredux: @DAN $XON The forum is a fantastic resource. I'm a new member (one month in) and already a handful of tips ($KITE $OPHT $SUNW $TEVA among others) from forum members have made me much more than the monthly cost of SMM. It's impossible to watch everything at all times, so I'm mega-grateful to the forum participants!
- DAN: @orpheusredux $XON $KITE $OPHT $SUNW $TEVA nice, orpheusredux. I wasn't aware that you've just been around for a month. Glad you're here. I read your posts all the time. Great stuff!
- orpheusredux: @DAN $XON $KITE $OPHT $SUNW $TEVA Means a lot coming from you, Dan. TY.
- orpheusredux: @tradeforfamily Likewise. Took profits in $KITE. Will look for bigger pullback to re-enter. $OPHT pulling back nicely. Will consider re-entering under 60.00
- tradeforfamily: @orpheusredux $KITE $OPHT Yes, The only one working for me today is Biotech $CYTK.
- orpheusredux: $KITE just keeps flying. Kissing the 200 DMA.
- orpheusredux: $KITE (left the $ off in my last post--sorry). $KITE flying and has broken out. Good buy on a pullback.
- orpheusredux: $KITE is still flying. Just shy of the 200 DMA and charts looks cup-and-handle-y. Earnings on 8-8.
- orpheusredux: $KITE I forgot to mention, $JUNO has not recovered significantly from its drop on 7-7; whereas $KITE, which many deemed unfairly punished for $JUNO's sins, has surged back.
- judysteiner: $KITE OUT 4.46 $$$$$
- judysteiner: $Kite phase 1 news
- woodman: #CAR-T #GeneTherapy #GeneEditing stocks are doing well. Some charts I like within the space: $AGTC $BLCM $EDIT $AGIO $LBIO $EIGR $TRIL $SRNE. Also $CLLS which may be on the verge of busting through the 200 day on 20 day support. Of course there are the crowd favorites too: $JUNO $KITE $BLUE . And don't forget $CNCR - the cancer immunotherapy ETF which holds a number of such stocks.
- mradams0621: @woodman $AGTC $BLCM $EDIT $AGIO $LBIO $EIGR $TRIL $SRNE $CLLS $JUNO $KITE $BLUE $CNCR #CAR-T #GeneTherapy #GeneEditing Nice 59min trade on news on $RPRX today. Gap and crap and Go. $1.18 down $0.96 up $2.00 Nice double if you could get most of it. Of coarse I only paper traded it so it's still beans and franks for dinner. CouldaWouldaShoulda trade.
- woodman: @mradams0621 $AGTC $BLCM $EDIT $AGIO $LBIO $EIGR $TRIL $SRNE $CLLS $JUNO $KITE $BLUE $CNCR $RPRX #CAR-T #GeneTherapy #GeneEditing I saw it "too" late and didn't get involved. It probably moved up a measly 30% up after that. :(
- woodman: @Aragorn $EDIT - great trading for anyone who got in this. Ride it as long as you can. But I wouldn't get enamored. It's moved so far so fast. It's been trading for one month and it's already sporting over a 1.3 billion market cap which is bigger than a lot of companies in the CAR-T/gene therapy-editing space. Bigger than $KITE $BLCM $BLUE $ZIOP $CLLS (one that also flew high in 2 months time then fell to earth). It's still in the pre-clinical / discovery phase. I don't believe they have anything even in IND enabling phase, much less Phase 1 yet. And I don't think anyone can know the "right" value of this company yet.
- Hackberry: $JUNO $KITE Continue power moves on volume. $KITE breaking 50 day today.
- Hackberry: $KITE $JUNO nice moves on volume. Many moves today. Not too many on volume.
- GreenGhost: $KITE 2ndary announced here; news was out prior ( surprise!) judging by price action sold shares on 12/1 after holding for 10 months ; stock has been crushed for last week and half and is breaking support ; don't go there IMO ; kept OOM ( was covered) Calls and bought cheapie upside long call against for protection now BECS CR spread ; absent a takeover ( very unlikely with 2ndary) that should expire worthless next week stock down yet another 5% this morning on news; over 25% from recent 90 area high
- traderbren: $KITE - seems to be defying gravity today. NP.
- DAN: @TRICIA $RLYP $ISIS $KITE -- very nice...in a really crappy market environment.
- DAN: I want to get a head start on the Weekend Update because (1) I won't be around next week to discuss/update; and (2) I'm seeing some potential opportunities relative to the broader market, and I don't want to wait until the weekend to describe what th ...
- traderbren: $KITE -- impressive come back. Sold my position on Tuesday. They report after the bell. Too risky for me to hold over earnings.
- traderbren: $KITE -- continues to move higher.
- DAN: @traderbren $KITE Earnings on Thursday. I really like the way KITE is trading now...but the earnings catalyst is a bit scary (particularly since I don't know much about the company other than that it's in the immunotherapy industry along with $JUNO and a few other).
- traderbren: @DAN $KITE $JUNO - thanks for the heads up Dan. Agreed, very scary with earnings looming. Holding a small position from lower level, but may look to come out if today's pop weakens. $JUNO acting well too, but NP. Thankfully came away with some dough on $JUNO some months ago before it cratered.
- traderbren: $CMG, $ADXS, $CLDX, $KITE, $GPRO -- seeing a nice run this AM.
- GreenGhost: $KITE $JUNO getting blasted both off 8% long both partial hedged w/CCs as LT holds ; suspect $BLUE sympathy trade that one get crushed too down 17% ( see earlier post on same) or some other unknown to me new bearish CART catalyst(s) now on radar this morning.
- TRICIA: #ASH2015 Dec 5 expect CARt and Gene Tx cos. ($BLUE, $JUNO, $KITE, $SGMO etc) to be very volatile .. no pos but eyeing beaten down BLUE and maybe a little KITE .
- TRICIA: Oppy: $CLLS now up 11% believe this data highly disruptive to CAR-T space, relevant to $KITE $JUNO. Abstract release Nov. 5, Late-breaker release Nov.16 checks suggest first-human data for UCART19 will be presented, well ahead of 1H16 expectations In @ 28.38 (waited too long but still good)
|Stock Price||$USD 179.79|
Kite Pharma Inc is a clinical-stage bio pharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells.Request Video of KITE
Already a member? Sign in here.
- November 9th, 2017 - 2017 Q3 Earnings
- $USD 23.86 576.27%
- $USD 19.67 66.56%
- $USD 63.44 60.13%
- $USD 5.88 -141.97%
- $USD 6.55 -41.81%
- $USD 7.95 -37.35%
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 14 day FREE membership. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 50,800 stock analysis videos
- Access an ever expanding library (50,800) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Your Stock Market Mentor membership comes with a 14 day, no questions asked, 100% money back guarantee!